Filing metadata

Accession number
0001415889-25-000669
Form type
Form 3/A
Filer
Janux Therapeutics, Inc.
CIK
CIK 1817713
Filed
Jan 03, 2025
Reporting period
Jan 01, 2023
Description
Initial ownership

Explore SEC Filings Hub